Article thumbnail

Photolyases: Capturing the light to battle skin cancer

By G.A. (George) Garinis, J. (Judith) Jans and G.T.J. (Gijsbertus) van der Horst

Abstract

Photolyases comprise efficient enzymes to remove the major UV-induced DNA lesions, cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs). While photolyases are present in all three kingdoms of life (i.e., bacteria, prokaryotes and eukaryotes), placental mammals appear to have lost these enzymes when they diverted from marsupials during evolution. Consequently, man and mice have to rely solely on the more complex and, for these lesions, less efficient nucleotide excision repair (NER) system. To assess the relative contribution of CPDs and 6-4PPs to the cytotoxic and genotoxic effects of the UV component of sunlight, we have recently generated a comprehensive set of transgenic mice expressing CPD and/or 6-4PP photolyases. Here, we discuss the use of photolyase transgenic mice as effective tools to study the adverse effects of UV irradiation

Topics: 6-4 photoproducts, Cyclobutane, Photolyases, Pyrimidine dimers, Skin cancer, Transgenic mice, UV
Publisher: 'Future Medicine Ltd'
Year: 2006
DOI identifier: 10.2217/14796694.2.2.191
OAI identifier: oai:repub.eur.nl:74895
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://repub.eur.nl/pub/74895 (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.